Cell Response and Regulation

CRR Membership Directory

cell response and regulation research programCell Response and Regulation (CRR) program conducts basic research on the fundamental cellular mechanisms that are deregulated in cancer cells. This discovery science provides new insight into cancer pathways and potential biomarkers.

The CRR program brings together scientists with shared research interests in three main thematic areas:

  • Mechanisms underlying cell turnover, including cell division, checkpoints, cell death, and stem cells, as well as their dysregulation in cancer in order to identify and characterize cancer targets.
  • Aberrant signaling in cancer and mechanisms of drug resistance, including signaling molecules and pathways relevant to drug resistance and cancer treatment.
  • Mechanisms and pathways mediating cell adhesion, motility, and metastasis, including developing an understanding of how cancer cells acquire the capability to reach distant sites and grow in those environments, which is critical for eventual therapeutic or preventative targeting.

CRR Program Newsletters

CRR 2016 Winter Newsletter
CRR 2015 Summer Newsletter

Previous newsletters are available upon request.
Please email vanessa.tuckett@hci.utah.edu.

Program achievements include an improved understanding of the machinery that executes cell division, elucidation of signaling pathways involved in epithelial homeostasis and migration, and identification of a new biomarker for breast cancer, a critical mediator of drug resistance in myeloma, and factors that drive brain tumor and melanoma metastasis. A major asset of the CRR Program is the development of robust high-fidelity preclinical models of cancer. Basic CRR Program discoveries are leading to early phase clinical trials in breast cancer and melanoma and have impacted a chemoprevention trial in colon cancer.

The CRR Program led by Katharine Ullman, PhD, and draws its members from many academic units on campus, providing a forum for interdepartmental communication among individuals who share a common interest in understanding the cellular basis of cancer. The CRR Program stimulates scientific exchange and promotes cancer-focused transdisciplinary research by capitalizing on opportunities to link the diverse expertise in techniques and model systems in synergistic projects. This extends across Cancer Center Programs and is further promoted by the interface with disease-oriented teams.

The Cell Response and Regulation Program received $9.8 million in total research support from the National Institutes of Health, the American Cancer Society, the National Science Foundation, and other funding agencies in 2013, with 34% coming from the National Cancer Institute. Cancer-focused articles published between 2009-2013 total 212, of which 37% are inter-programmatic and 18% are intra-programmatic publications.

Katharine S. Ullman, PhD

katherine ullman
HCI, Room 5345

CRR Membership Directory 


Name E-mail Research Interests Website
Beckerle, MaryMary Beckerle e-mail Cell adhesion, cell migration, Ewing sarcoma website
Christian, JanJan Christian e-mail Neurobiology and Internal Medicine
Cohen, MichaelMichael Cohen e-mail Anatomic pathology; urologic cancer
Factor, RachelRachel Factor e-mail
Breast cancer pathology
Frost, AdamAdam Frost e-mail
Mechanisms of cellular physiology; understanding how malignancy changes these mechanisms
Fults, DanielDaniel Fults e-mail
Defective signaling in medulloblastoma and metastasis
Grossman, DouglasDoug Grossman e-mail Apoptotic mechanisms underlying skin cancer development, with a focus on the apoptosis and cell cycle regulator, Survivin; oxidative stress in melanoma website
Grossmann, AllieImage Coming Soon e-mail Anatomic pathology
Holmen, SheriSheri Holmen e-mail Identifying and validating novel molecular targets for cancer therapy website
Kadrmas, JulieJulie Kadrmas e-mail Cell adhesion, cell migration, Ewing sarcoma
Li,DeanDean Li e-mail Signaling in angiogenesis; targeting angiogenesis in cancer
Lim, CarolCarol Lim e-mail Targeting apoptotic mechanisms in cancer cells
McMahon, MartinMartin McMahon e-mail Mechanisms underlying the development of metastatic melanoma, lung and thyroid cancer
Mendoza, MichelleImage Coming Soon e-mail How cell movement is controlled and how to exploit these controls to block cancer dissemination
Moos, PhilipPhilip Moos e-mail Redox dysregulation in cancer, selenoprotein function in cancer
Murtaugh, CharlesCharles Murtaugh e-mail Pancreatic development and cancer
O'Hare, ThomasThomas OHare e-mail
Target discovery and inhibitor development for chronic leukemia,
Oliver, TrudyTrudy Oliver e-mail Mouse models of lung cancer; chemotherapeutic resistance; p53 regulation website
Rosenblatt, JodyJody Rosenblatt e-mail
Mechanisms and regulation of cell death and division, novel mechanisms forinitiating tumor cell metastasis
Round, JuneJune Round e-mail
The human microbiome and its influence on host immune response and tumorigenesis
Stafforini, DianaDiana Stafforini e-mail
Role of inflammation in colon and prostate cancer
Stanfield, GillianGillian Stanfield e-mail Cell motility
Stewart, RodneyRodney Stewart e-mail
Cell survival and migration during embryogenesis neural crest-derived cancers
Sundquist, WesleyWesley Sundquist e-mail Cytokinesis and membrane trafficking website
Topham, MatthewMatthew Topham e-mail
Lipid signaling in colon and lung cancer
Katharine UllmanUllman, Katharine e-mail Cell division, biomarkers and tumor suppressors in breast cancer website
VanBrocklin, MatthewMatthew VanBrocklin e-mail
Identifying novel molecular therapeutic targets in lung cancer and melanoma, chemoresistance
Welm, AlanaAlana Welm e-mail Breast cancer and metastasis website
Welm, BryanImage Coming Soon e-mail Understand the cause of breast cancer by identifying the cellular origins for cancer and the initial transforming events within those cells
Williams, MatthewMatthew Williams e-mail Cellular and molecular signals regulating differentiation and cell fate decisions of activated T cells infiltrating tumors
Zimmerman, GuyGuy Zimmerman e-mail Cell adhesion and inflammation, thrombosis in cancer